Company profile
Phio Pharmaceuticals Corp.
NASDAQ:PHIOBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06014086 | phase1 | active_not_recruiting | 2023-11-07 | 2025-12-29 | Phio Pharmaceuticals Inc. | Intratumoral PH-762 for Cutaneous Carcinoma |
FDA applications (0)
No records yet.